Oncopeptide Leadership News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncopeptide leadership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncopeptide Leadership Today - Breaking & Trending Today

Oncopeptides AB: Oncopeptides publishes Q1 report 2022

STOCKHOLM, May 4, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Lancet Haematology , Oncopeptide Leadership , Global Head , Corporate Communications , Swedish Financial Instruments Trading , Mid Cap ,

Oncopeptides publishes Q1 report 2022

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Lancet Haematology , Oncopeptide Leadership , Global Head , Corporate Communications , Swedish Financial Instruments Trading , Mid Cap , Oncopeptides Ab ,

Oncopeptides AB: Invitation to presentation of Q1 report

STOCKHOLM, April 27, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual General Meeting , Tuesday June , Oncopeptide Leadership , Global Head , Corporate Communications , Mid Cap ,

Invitation to presentation of Q1 report

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual General Meeting , Tuesday June , Oncopeptide Leadership , Global Head , Corporate Communications , Mid Cap , Oncopeptides Ab ,

Invitation to presentation of Q1 report

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual General Meeting , Tuesday June , Oncopeptide Leadership , Global Head , Corporate Communications , Mid Cap ,